Which laboratory tests should be ordered to evaluate a patient with suspected hypoglycemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Laboratory Tests for Hypoglycemia Evaluation

When evaluating suspected hypoglycemia, obtain a critical blood panel during an episode when plasma glucose is <60 mg/dL (3.3 mmol/L): plasma glucose, insulin, C-peptide, proinsulin, β-hydroxybutyrate, and screen for oral hypoglycemic agents 1.

Core Diagnostic Strategy

The evaluation hinges on capturing biochemical data during actual hypoglycemia, not at random times. The Endocrine Society guidelines provide the definitive framework 1:

Essential Labs During Hypoglycemia (glucose <60 mg/dL)

Primary panel:

  • Plasma glucose (laboratory-measured, not point-of-care)
  • Insulin (≥3 μU/mL indicates hyperinsulinism)
  • C-peptide (≥0.6 ng/mL or 0.2 nmol/L indicates endogenous insulin)
  • Proinsulin (≥5.0 pmol/L supports insulinoma)
  • β-hydroxybutyrate (≤2.7 mmol/L confirms insulin-mediated suppression of ketogenesis)
  • Oral hypoglycemic agent screen (sulfonylureas, meglitinides)

Additional tests:

  • Insulin antibodies (can be measured later, not necessarily during hypoglycemia)
  • Glucagon stimulation test: After documenting hypoglycemia, inject 1 mg IV glucagon and measure glucose at 10,20, and 30 minutes. A rise ≥25 mg/dL (1.4 mmol/L) indicates preserved glycogen stores and insulin excess 1, 2.

Clinical Context Determines Testing Approach

For Suspected Fasting Hypoglycemia

Perform a supervised 72-hour fast 1:

  • Measure glucose, insulin, C-peptide, proinsulin, and β-hydroxybutyrate every 6 hours initially
  • When glucose drops <60 mg/dL, increase sampling to every 1-2 hours
  • End the fast when:
    • Glucose <45 mg/dL (2.5 mmol/L) WITH symptoms/signs, OR
    • Glucose <55 mg/dL (3.0 mmol/L) if Whipple's triad previously documented, OR
    • 72 hours elapsed

Critical pitfall: Don't end the fast based solely on low glucose without symptoms—healthy women and children can have low fasting glucose 1.

At fast termination, obtain the complete panel above plus glucagon stimulation test 1.

For Suspected Postprandial Hypoglycemia

Perform a mixed-meal test (NOT oral glucose tolerance test) 1, 2:

  • Use a meal similar to what triggers symptoms (or 50-60% carbohydrate mixed meal)
  • Sample glucose, insulin, C-peptide, and proinsulin at baseline and every 30 minutes for 5 hours
  • Only send insulin, C-peptide, and proinsulin for analysis when glucose <60 mg/dL 1
  • If Whipple's triad occurs, add oral hypoglycemic screen and insulin antibodies 1

Important: An oral glucose tolerance test should never be used for hypoglycemia evaluation 1, 2.

Diagnostic Thresholds for Hyperinsulinemic Hypoglycemia

When glucose is <55 mg/dL (3.0 mmol/L), the following indicate endogenous hyperinsulinism 1, 2:

  • Insulin ≥3 μU/mL (18 pmol/L)
  • C-peptide ≥0.6 ng/mL (0.2 nmol/L or 200 pmol/L)
  • Proinsulin ≥5.0 pmol/L
  • β-hydroxybutyrate ≤2.7 mmol/L
  • Glucose rise ≥25 mg/dL after glucagon

These values appear inappropriately elevated relative to the low glucose, not necessarily high in absolute terms 1.

Initial Screening Before Provocative Testing

Before subjecting patients to prolonged fasts or meal tests 1:

  1. Review medication list (insulin, sulfonylureas, alcohol, others)
  2. Assess for critical illness (sepsis, liver/renal failure)
  3. Check cortisol and ACTH if adrenal insufficiency suspected
  4. Examine for large tumors (non-islet cell tumors producing IGF-II)

If spontaneous hypoglycemia is captured with symptoms, obtain the critical panel immediately—this may obviate need for formal testing 2.

Key Distinctions in Lab Interpretation

Exogenous insulin: High insulin, low C-peptide (suppressed endogenous production)

Sulfonylurea/meglitinide: High insulin, high C-peptide, positive drug screen

Insulinoma: High insulin, high C-peptide, high proinsulin, negative drug screen, no antibodies

Insulin autoimmune syndrome: High insulin, variable C-peptide, positive insulin antibodies 1

Common Pitfalls to Avoid

  • Don't rely on point-of-care glucose meters for diagnostic decisions—use laboratory plasma glucose 1
  • Don't measure insulin/C-peptide when glucose >60 mg/dL—results are uninterpretable 1
  • Don't use insulin:glucose ratios—they have no diagnostic utility 1
  • Don't diagnose based on symptoms alone—Whipple's triad (symptoms + documented low glucose + relief with treatment) must be confirmed 2

The 2009 Endocrine Society guideline remains the authoritative framework, emphasizing that proper timing of sample collection during documented hypoglycemia is more important than the breadth of testing 1.

Related Questions

What are the differential diagnoses of spontaneous (non‑iatrogenic) hypoglycaemia?
What are the causes of hypoglycemia?
How should I evaluate and manage a patient with new-onset hypoglycemia that persists throughout the day but improves after eating?
What are the causes and evaluation steps for an 80‑ to 90‑year‑old patient who frequently feels hypoglycemic and experiences severe hunger despite normal glucose measurements?
In a 24-year-old man with two documented episodes of hypoglycemia, one occurring after a meal, what is the appropriate workup?
In an otherwise asymptomatic patient with an ALT level 12 times the upper limit of normal, is right costovertebral (right upper‑quadrant back) pain a sign of impending liver failure?
In a 65-year-old woman with diabetes mellitus and a remote myocardial infarction who is in septic shock from urosepsis, receiving norepinephrine, remains hypoxic despite 100% FiO₂, has bilateral lung infiltrates on chest X‑ray, and pulmonary artery catheter data showing low right atrial pressure, low pulmonary artery pressure, low pulmonary capillary wedge pressure, and normal cardiac output, what is the most likely cause of the bilateral lung infiltrates?
What is the absolute increase in overall survival (OS) when L-asparaginase is added to the chemotherapy regimen for pediatric and adult acute lymphoblastic leukemia?
What is the mechanism by which Helicobacter pylori gastritis leads to oral lichen planus?
Are amlodipine and telmisartan hepatotoxic?
Is dapagliflozin hepatotoxic?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.